SABS
#3390
SAB Biotherapeutics, Inc. - Common Stock
3.7 3 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.36%
Monthly Change
+8.43%
6 month change
-6.75%
Year Change
+54.13%
Previous Close
3.8 2
Open
3.7 3
Low
3.7 3
High
3.7 3
Volume
22
Financials
- Market Capitalization 285.21 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.73
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3360 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | -4.76% | -4.19% | +72.04% | +24.03% | 296.45 M USD | ||
| 3386 |  MGNX MacroGenics, Inc. - Common Stock | 4.50 USD | +3.93% | -2.17% | +13.64% | +186.62% | 286.03 M USD | ||
| 3394 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.47 USD | +0.32% | +19.27% | +53.24% | -5.30% | 282.09 M USD | ||
| 3402 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.47 USD | +2.36% | -1.70% | -0.29% | -30.32% | 276.37 M USD |
Frequently asked questions about SAB Biotherapeutics, Inc. - Common Stock
What is the SAB Biotherapeutics, Inc. - Common Stock stock price today?
The current price of SAB Biotherapeutics, Inc. - Common Stock (SABS) is 3.73. Over the past 24 hours, the stock has changed by -2.36%. Follow the SABS chart for real-time price dynamics.
What is the stock ticker of SAB Biotherapeutics, Inc. - Common Stock?
SAB Biotherapeutics, Inc. - Common Stock trades under the ticker SABS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SAB Biotherapeutics, Inc. - Common Stock stock going up?
SABS has changed by -4.60% over the last week, +8.43% over the last month, and +54.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was SAB Biotherapeutics, Inc. - Common Stock net income for the last quarter?
SAB Biotherapeutics, Inc. - Common Stock reported net income of -18.87 M for the last quarter. The previous quarter showed -16.86 M, which means net income changed by -11.91%.
How many employees does SAB Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, SAB Biotherapeutics, Inc. - Common Stock has 86 employees. Workforce size can provide additional context about the company's scale and operations.
What is SAB Biotherapeutics, Inc. - Common Stock EBITDA?
SAB Biotherapeutics, Inc. - Common Stock EBITDA is -19.21 M, and its EBITDA margin is -37.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SAB Biotherapeutics, Inc. - Common Stock stock?
You can buy SAB Biotherapeutics, Inc. - Common Stock (SABS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SAB Biotherapeutics, Inc. - Common Stock stock?
Investing in SAB Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SABS chart and related analysis on metatrader.com as part of your research.